Related Experiment Video
Updated: Apr 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Maternal obesity and inpatient medication usage
C Kennedy1, N Farah, V O'Dwyer
1UCD Centre for Human Reproduction, Coombe Women and Infants University Hospital, Dublin, Ireland.
Maternal obesity increases inpatient medication use during pregnancy, particularly for analgesics and antibiotics. However, medication use during childbirth was similar across weight groups, indicating specific antenatal care needs for obese mothers.
Area of Science:
- Obstetrics and Gynecology
- Maternal Health
- Pharmacoeconomics
Background:
- Maternal obesity is a known risk factor for increased healthcare resource utilization in outpatient settings.
- Existing research highlights the association between maternal obesity and various medical and obstetric complications.
- The impact of maternal obesity on inpatient medication usage, specifically during the antenatal and peripartum periods, requires further investigation.
Purpose of the Study:
- To compare inpatient antenatal and peripartum medication usage between obese women and women with a normal body mass index (BMI).
- To identify specific medication categories and periods where maternal obesity influences inpatient drug administration.
- To assess the implications of these findings on healthcare costs associated with rising maternal obesity rates.
Main Methods:
- A comparative study involving 284 pregnant women, categorized by BMI into normal, overweight, and obese groups.
- Exclusion of women with diabetes mellitus through glucose tolerance testing at 28 weeks gestation.
- Retrospective collation of inpatient medication administration records from patient drug charts during the antenatal and peripartum periods.
Main Results:
- A trend towards increased antenatal medication usage was observed with rising BMI categories, notably in analgesics and antibiotics.
- No significant differences in peripartum medication usage were found across the different BMI groups.
- Maternal obesity was associated with increased inpatient medication administration specifically during the antenatal period.
Conclusions:
- Maternal obesity is linked to elevated inpatient medication requirements during the antenatal phase of pregnancy.
- The findings suggest potential increases in healthcare expenditure due to higher medication use in obese pregnant women.
- These results underscore the importance of managing maternal obesity to mitigate associated healthcare costs and resource utilization.
More Related Videos
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
11:44A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
Published on: September 27, 2017
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...